Sara Reina-Gutiérrez , Cátia Paixão , Patrícia Rebelo , Joana Antão , Vânia Fernandes , Pedro G. Ferreira , Alda Marques
{"title":"肺间质性疾病患者肺康复后股四头肌最大自主收缩的最小临床重要差异","authors":"Sara Reina-Gutiérrez , Cátia Paixão , Patrícia Rebelo , Joana Antão , Vânia Fernandes , Pedro G. Ferreira , Alda Marques","doi":"10.1016/j.rmed.2025.108351","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Skeletal muscle loss has a devastating effect on daily lives of people with interstitial lung disease (ILD). Pulmonary rehabilitation (PR) improves muscle strength; however, the lack of cut-off values to define clinical improvement limits the interpretability of the obtained gains.</div></div><div><h3>Objective</h3><div>To estimate the minimal clinically important difference (MCID) for quadriceps maximal voluntary contraction (QMVC) in people with ILD, assessed with hand-held dynamometry as an absolute value in kilogram-force (KgF) and as percentage of the predicted value (% pred), after PR in people with ILD.</div></div><div><h3>Methods</h3><div>A secondary analysis of data from three previous studies was conducted. Participants took part in a 12-week community-based PR programme. The MCIDs were computed using anchor- and distribution-based methods. Anchors explored were the 1-min sit-to-stand (1-min STS) test, the 6-min walking distance, handgrip strength, modified Medical Research Council questionnaire, St. George's Respiratory Questionnaire and Functional Assessment of Chronic Illness Therapy-Fatigue Subscale. The pooled MCIDs were computed using the weighted arithmetic mean (2/3 anchor and 1/3 distribution-based methods).</div></div><div><h3>Results</h3><div>Fifty-nine people with ILD (61 % female, 66 ± 11years) were included in the analysis. The 1-min STS test was the only anchor fitting the criteria. There were significant improvements after PR in the QMVC (mean difference = 3.9 ± 8.2 KgF and median difference = 10.9 [1.6; 22.0] % pred, p < 0.001) and 1-min STS test (mean difference = 6.6 ± 7.1 repetitions, p < 0.001). The pooled MCIDs were 3.2 KgF and 10.6 % pred.</div></div><div><h3>Conclusion</h3><div>An increase of at least 3.2 KgF or 10.6 % pred for QMVC in people with ILD after PR represents clinically relevant improvements.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"248 ","pages":"Article 108351"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Minimal clinically important difference for quadriceps maximal voluntary contraction following pulmonary rehabilitation in people with interstitial lung disease\",\"authors\":\"Sara Reina-Gutiérrez , Cátia Paixão , Patrícia Rebelo , Joana Antão , Vânia Fernandes , Pedro G. Ferreira , Alda Marques\",\"doi\":\"10.1016/j.rmed.2025.108351\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Skeletal muscle loss has a devastating effect on daily lives of people with interstitial lung disease (ILD). Pulmonary rehabilitation (PR) improves muscle strength; however, the lack of cut-off values to define clinical improvement limits the interpretability of the obtained gains.</div></div><div><h3>Objective</h3><div>To estimate the minimal clinically important difference (MCID) for quadriceps maximal voluntary contraction (QMVC) in people with ILD, assessed with hand-held dynamometry as an absolute value in kilogram-force (KgF) and as percentage of the predicted value (% pred), after PR in people with ILD.</div></div><div><h3>Methods</h3><div>A secondary analysis of data from three previous studies was conducted. Participants took part in a 12-week community-based PR programme. The MCIDs were computed using anchor- and distribution-based methods. Anchors explored were the 1-min sit-to-stand (1-min STS) test, the 6-min walking distance, handgrip strength, modified Medical Research Council questionnaire, St. George's Respiratory Questionnaire and Functional Assessment of Chronic Illness Therapy-Fatigue Subscale. The pooled MCIDs were computed using the weighted arithmetic mean (2/3 anchor and 1/3 distribution-based methods).</div></div><div><h3>Results</h3><div>Fifty-nine people with ILD (61 % female, 66 ± 11years) were included in the analysis. The 1-min STS test was the only anchor fitting the criteria. There were significant improvements after PR in the QMVC (mean difference = 3.9 ± 8.2 KgF and median difference = 10.9 [1.6; 22.0] % pred, p < 0.001) and 1-min STS test (mean difference = 6.6 ± 7.1 repetitions, p < 0.001). The pooled MCIDs were 3.2 KgF and 10.6 % pred.</div></div><div><h3>Conclusion</h3><div>An increase of at least 3.2 KgF or 10.6 % pred for QMVC in people with ILD after PR represents clinically relevant improvements.</div></div>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":\"248 \",\"pages\":\"Article 108351\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0954611125004147\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125004147","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Minimal clinically important difference for quadriceps maximal voluntary contraction following pulmonary rehabilitation in people with interstitial lung disease
Background
Skeletal muscle loss has a devastating effect on daily lives of people with interstitial lung disease (ILD). Pulmonary rehabilitation (PR) improves muscle strength; however, the lack of cut-off values to define clinical improvement limits the interpretability of the obtained gains.
Objective
To estimate the minimal clinically important difference (MCID) for quadriceps maximal voluntary contraction (QMVC) in people with ILD, assessed with hand-held dynamometry as an absolute value in kilogram-force (KgF) and as percentage of the predicted value (% pred), after PR in people with ILD.
Methods
A secondary analysis of data from three previous studies was conducted. Participants took part in a 12-week community-based PR programme. The MCIDs were computed using anchor- and distribution-based methods. Anchors explored were the 1-min sit-to-stand (1-min STS) test, the 6-min walking distance, handgrip strength, modified Medical Research Council questionnaire, St. George's Respiratory Questionnaire and Functional Assessment of Chronic Illness Therapy-Fatigue Subscale. The pooled MCIDs were computed using the weighted arithmetic mean (2/3 anchor and 1/3 distribution-based methods).
Results
Fifty-nine people with ILD (61 % female, 66 ± 11years) were included in the analysis. The 1-min STS test was the only anchor fitting the criteria. There were significant improvements after PR in the QMVC (mean difference = 3.9 ± 8.2 KgF and median difference = 10.9 [1.6; 22.0] % pred, p < 0.001) and 1-min STS test (mean difference = 6.6 ± 7.1 repetitions, p < 0.001). The pooled MCIDs were 3.2 KgF and 10.6 % pred.
Conclusion
An increase of at least 3.2 KgF or 10.6 % pred for QMVC in people with ILD after PR represents clinically relevant improvements.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.